According to the SEC Form 4 filings, Parker Geoffrey M., being in a position of
No biography is available at this moment.
Buys | $106,350 | 1 | 33 |
Sells | $90,940 | 2 | 67 |
| 2026-10-21 | Sale | Allogene Therapeutics, Inc. ALLO | CHIEF FINANCIAL OFFICER | 36,342 0.0106% | $1.34 | $48,698 | -7.52% | |
| 2026-02-02 | Sale | Allogene Therapeutics, Inc. ALLO | CHIEF FINANCIAL OFFICER | 24,001 0.0101% | $1.76 | $42,242 | +8.29% | |
| 2025-11-12 | Perrigo Company plc PRGO | director | 7,500 0.0054% | $14.18 | $106,350 | -4.44% | ||
| 2025-10-21 | Sale | Allogene Therapeutics, Inc. ALLO | CHIEF FINANCIAL OFFICER | 36,744 0.0165% | $1.26 | $46,169 | +48.41% | |
| 2025-08-18 | Perrigo Company plc PRGO | director | 4,375 0.0032% | $22.97 | $100,497 | -40.18% | ||
| 2025-05-12 | Perrigo Company plc PRGO | director | 3,500 0.0026% | $27.10 | $94,850 | -41.58% | ||
| 2025-02-03 | Sale | Allogene Therapeutics, Inc. ALLO | CHIEF FINANCIAL OFFICER | 4,361 0.002% | $1.73 | $7,545 | -19.16% | |
| 2024-01-30 | Allogene Therapeutics, Inc. ALLO | CHIEF FINANCIAL OFFICER | 190 0.0001% | $3.60 | $683 | -25.56% | ||
| 2023-06-13 | Perrigo Company plc PRGO | director | 10,000 0.0074% | $33.06 | $330,637 | -2.48% | ||
| 2023-03-06 | Perrigo Company plc PRGO | director | 5,000 0.0038% | $38.05 | $190,270 | -8.22% | ||
| 2021-12-16 | Perrigo Company plc PRGO | director | 10,000 0.0075% | $36.85 | $368,540 | +4.81% | ||
| 2021-03-17 | Perrigo Company plc PRGO | director | 5,000 0.0037% | $41.29 | $206,436 | +2.15% | ||
| 2018-11-12 | Perrigo Company plc PRGO | director | 3,000 0.0022% | $65.35 | $196,058 | -23.91% | ||
| 2016-11-21 | Perrigo Company plc PRGO | director | 2,500 0.0017% | $88.75 | $221,875 | -13.65% |